Article actualité

XENIOS AG, the technology and therapy leader in lung and heart assist becomes part of Fresenius Medical Care & Co. KGaA, Germany’s largest medical device company. - www.XENIOS-ag.com

XENIOS is driving innovation in minimally invasive lung and heart assist, and is first to offer a complete product range that runs on a common platform.

Fresenius Medical Care is a global market leader...

altLes points clés

En métropole, légère augmentation de l'activité grippale par rapport à la semaine précédente.
Antilles-Guyane : début de l'épidémie en Guadeloupe et décroissance de l'épidémie en Guyane.
A la Réunion : fin de la deuxième vague épidémique.

InterSystems au cœur des améliorations de la qualité des soins prodigués au patient pour les 45.000 habitants des iles écossaises




Paris, le 9 Novembre 2016 - Grâce à la solution TrakCare d'InterSystems, les 45.000 habitants des Iles écossaises Shetland et Orknet vont bénéficier d'un nouveau système de partage des informations médicales et avoir accès au système...

Les Cayes, Haiti, 8 November 2016 (PAHO/WHO) - A large contingent of national supervisors, nurses, health workers and criesurs, or town criers, are being mobilized by the Ministry of Health and Population of Haiti to vaccinate some 800,000 people living in 16 communes in the departments of Sud and Grand'Anse, the areas most affected by Hurricane Mathew a month ago.

The campaign, which...

Novozymes Fermax™ is an enzyme that replaces chemicals in the sugarcane ethanol production process.


COPENHAGEN, Denmark – November 8, 2016 –  Today, Novozymes launches Fermax, an enzyme protease that prevents foam development during the sugarcane ethanol fermentation process, while delivering improved control and replacing chemicals. For an average size plant, trialing partners also...

London – 8 November 2016 - Positive topline results have been announced by Alkermes for its Phase III study of ALKS-5461 as an adjunctive therapy for major depressive disorder (MDD), according to research and consulting firm GlobalData.

As explored in GlobalData’s most recent MDD report, ALKS-5461 is one of six late-stage pipeline products showing promise with regards to improving...

Viaskin Milk est le produit candidat en phase de développement clinique le plus avancé pour le traitement de l'allergie aux protéines de lait de vache IgE-médiée



La Food and Drug Administration (FDA) a accordé le statut de « Fast Track » à Viaskin Milk en septembre 2016




DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : DBVT), société biopharmaceutique...

7 NOVEMBER 2016 | GENEVA – The World Health Organization (WHO) has issued a new series of recommendations to improve quality of antenatal care in order to reduce the risk of stillbirths and pregnancy complications and give women a positive pregnancy experience.
Last year, an estimated 303 000 women died from pregnancy-related causes, 2.7 million babies died during the first 28 days of life...

Vitrines Sociétés

Voir toutes les vitrines